• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

IFITM3 Affects the Level of Antibody Response after Influenza Vaccination

tetano

Editor, Senior Moderator
Emerg Microbes Infect. 2020 Apr 23:1-29. doi: 10.1080/22221751.2020.1756696. [Epub ahead of print]
IFITM3 Affects the Level of Antibody Response after Influenza Vaccination.


Lei N[SUP]1,[/SUP][SUP]2[/SUP], Li Y[SUP]1[/SUP], Sun Q[SUP]1,[/SUP][SUP]3[/SUP], Lu J[SUP]1[/SUP], Zhou J[SUP]1[/SUP], Li Z[SUP]1[/SUP], Liu L[SUP]1[/SUP], Guo J[SUP]1[/SUP], Qin K[SUP]1[/SUP], Wang H[SUP]2[/SUP], Zhao J[SUP]2[/SUP], Li C[SUP]2[/SUP], Sun L[SUP]2[/SUP], Wang D[SUP]1[/SUP], Zhao Z[SUP]4[/SUP], Shu Y[SUP]1,[/SUP][SUP]3[/SUP].

Author information




Abstract

Interferon-induced transmembrane protein 3 (IFITM3) as an antiviral factor can inhibit replication of several viruses including influenza virus. A single-nucleotide polymorphism rs12252-C of IFITM3 results in a truncated IFITM3 protein lacking its first 21 amino acids, which is much higher in the Han Chinese population and associated with severe illness in adults infected with pandemic influenza H1N1/09 virus. To investigate if IFITM3 or IFITM3 rs12252-C could affect the antibody response after influenza vaccination, we detected the haemagglutination inhibition (HI) of 171 healthy young adult volunteers (IFITM3 rs12252-C/C, C/T, T/T carriers) and in an IFITM3-deletion mouse model (Ifitm3[SUP]-/-[/SUP]) after trivalent inactivated vaccine (TIV) immunization. Seroconversion rates for H1N1, H3N2 and B viruses in IFITM3 rs12252-C/C genotype carriers was lower compared with C/T and T/T donors. Significantly lower levels of specific antibodies to H1N1, H3N2 and B viruses and total IgG were observed in Ifitm3[SUP]-/-[/SUP] mice. Correspondingly, the numbers of splenic germinal center (GC) B cells, plasma cells, TIV-specific IgG[SUP]+[/SUP] antibody secreting cells and T follicular helper cells in Ifitm3[SUP]-/-[/SUP] mice were lower compared with wild type mice. However, the number of memory B cells was higher in Ifitm3[SUP]-/-[/SUP] mice at day 7 after booster. The HI level of Ifitm3[SUP]-/-[/SUP] mice remained lower than WT mice after third vaccination. Moreover, the transcriptional network regulating GC B cell and plasma cell differentiation was abnormal in Ifitm3[SUP]-/-[/SUP] mice. Our results indicate that IFITM3 deletion attenuated the antibody response. The mechanism of influenza-IFITM3 interactions affecting the antibody response requires further investigation.



KEYWORDS:

IFITM3; Immune response; Influenza virus; Interferon-induced transmembrane protein 3; SNP rs12252; Trivalent inactivated vaccine


PMID:32321380DOI:10.1080/22221751.2020.1756696
Free full text
 
Back
Top Bottom